We thank the reader for his comments and providing us the opportunity to
further discuss the controversies in the management of PDA in VLBW
infants. We agree with the reader that spontaneous closure of PDA is
significantly high in VLBW infants with birth weight >1000g [1-2], and
the presence of PDA is associated with significant morbidity and
mortality in infants of gestational age <25 weeks [3]. However, it is
not clear from the literature where to draw the demarcation line as far
as the birth weight is concerned. An unpublished audit done in our
department revealed that birth weight was a better predictor than
gestational age with regard to PDA-related morbidities. We found that
morbidities such as massive pulmonary hemorrhage and severe
intra-ventricular hemorrhage were significantly higher in babies with
birth weight less than 800g with untreated PDA, regardless of
gestational age. Hypothermia, peri-natal asphyxia, lack of antenatal
steroids and intrauterine growth retardation were additional risk
factors.
If treatment for the PDA is based on clinical
judgment alone, we might end up in over treating it, and exposing the
neonates to treatment - related morbidities. Hence we recommend that the
treatment strategies should be based on birth weight as well, in
addition to hemodynamic significance of PDA and need for assisted
ventilation.
References
1. Nemerofsky SL, Parravicini E, Bateman D, Kleinman
C, Polin RA, Lorenz JM. The ductus arteriosus rarely requires treatment
in infants >1000 grams. Am J Perinatol. 2008;25:661-6.
2. Clyman R, Narayanan M. Patent ductus arteriosus: a
physiologic basis for current treatment practices. In: Current
Topics in Neonatology. Philadelphia:WB Saunders. 2007. p. 71-97.
3. Tauzin L, Joubert C, Noel AC, Bouissou A, Moulies ME. Effect of
persistent patent ductus arteriosus on mortality and morbidity in very
low-birthweight infants. Acta Pediatr. 2012;101:419-23.